These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 23682717)

  • 1. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structure breakthroughs in the GPCR transmembrane region.
    Topiol S; Sabio M
    Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of GPCR structures in drug design.
    Congreve M; Langmead C; Marshall FH
    Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PREDICT modeling and in-silico screening for G-protein coupled receptors.
    Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
    Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based and fragment-based GPCR drug discovery.
    Andrews SP; Brown GA; Christopher JA
    ChemMedChem; 2014 Feb; 9(2):256-75. PubMed ID: 24353016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling G protein-coupled receptors and their interactions with ligands.
    Costanzi S
    Curr Opin Struct Biol; 2013 Apr; 23(2):185-90. PubMed ID: 23415855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of novel G protein coupled receptors.
    Davies MN; Flower DR
    Methods Mol Biol; 2009; 528():25-36. PubMed ID: 19153682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise.
    Yarnitzky T; Levit A; Niv MY
    Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the 3D structure of GPCRs: advances and application to drug discovery.
    Becker OM; Shacham S; Marantz Y; Noiman S
    Curr Opin Drug Discov Devel; 2003 May; 6(3):353-61. PubMed ID: 12833668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of in silico drug screening results for G-protein-coupled receptors by using universal active probes.
    Wada M; Kanamori E; Nakamura H; Fukunishi Y
    J Chem Inf Model; 2011 Sep; 51(9):2398-407. PubMed ID: 21848279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
    Filizola M; Weinstein H
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current assessment of docking into GPCR crystal structures and homology models: successes, challenges, and guidelines.
    Beuming T; Sherman W
    J Chem Inf Model; 2012 Dec; 52(12):3263-77. PubMed ID: 23121495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.